Drawing for CHI-MED HUTCHISON CHINA MEDITECH LTD

USPTO serial 78860107

CHI-MED HUTCHISON CHINA MEDITECH LTD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ORNDORFF, LINDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHI-MED HUTCHISON CHINA MEDITECH LTD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN, FRAYNE & SCHWAB666 3RD AVENEW YORK, NY 10017-5621UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal and pharmaceutical preparations for use in the treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; digestive preparations for medical use; herbal preparations for use in the treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; herbal supplements; Chinese medicines for use in the treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; vitamin and mineral preparations and supplements; dietetic substances for medically restricted diets; biological and dietetic food and beverages for medically restricted diets; health food supplements, nutritional supplements, and nutritional food additives for medically restricted diets; baby and infant food; medicinal oils, fish oils, cod liver oil, tuna oil, evening primrose oil, micro-encapsulated oils, emulsified oil, all for use in the treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systemsACTIVE—
035Retail store services provided on-line from a computer database and the Internet and retail store services, all featuring medicinal and pharmaceutical preparations, digestive preparations, herbal preparations and supplements, Chinese medicines, vitamin and mineral preparations and supplements, dietetic substances, dietetic food and beverages adapted for medicinal purposes, biological and dietetic food preparations for medicinal purposes, health food supplements, and food additives for medicinal purposes, baby and infant food, medicinal oils, fish oils, cod liver oil, tuna oil, evening primrose oil, micro-encapsulated oils, emulsified oil, nutritional and dietetic substances in capsule or tablet form, all for medicinal purposes; advertising agency services; providing business information; promotion and marketing services; business management and advisory services, namely, assisting business in the formation of business plans and policies relating to medicine, personal health, diet and nutrition; business advisory and consultancy services; franchising services, namely, consultancy and assistance in business management, organization and promotion; Prescription services, namely, providing retail pharmacy servicesACTIVE—
042Medical research in the diagnosis of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; providing specific information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substances, on-line and by the Internet to customers upon request; providing temporary use of non-downloadable software over the Internet for tracking documents and for providing information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substancesACTIVE—
044Prescription services, namely, dispensing of pharmaceuticals and providing pharmaceutical advice; diagnosis services, namely, performing diagnosis of diseases; medical care services, medical clinics, consultancy and advisory services in the field of medical careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 8, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 8, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 22, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Apr 21, 2010EX5GSOU EXTENSION 5 GRANTED—
Apr 20, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 29, 2010EXT5SOU EXTENSION 5 FILED—
Mar 29, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 23, 2009EX4GSOU EXTENSION 4 GRANTED—
Oct 22, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 7, 2009EXT4SOU EXTENSION 4 FILED—
Oct 7, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2009EX3GSOU EXTENSION 3 GRANTED—
Mar 25, 2009EXT3SOU EXTENSION 3 FILED—
Mar 25, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 2, 2008EX2GSOU EXTENSION 2 GRANTED—
Oct 2, 2008EXT2SOU EXTENSION 2 FILED—
Oct 2, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2008EX1GSOU EXTENSION 1 GRANTED—
Apr 8, 2008EXT1SOU EXTENSION 1 FILED—
Apr 8, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 9, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 17, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 27, 2007NPUBNOTICE OF PUBLICATION—
May 4, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 4, 2007ALIEASSIGNED TO LIE—
Apr 16, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2007DOCKASSIGNED TO EXAMINER—
Oct 3, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2006DOCKASSIGNED TO EXAMINER—
Apr 20, 2006MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 19, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance